Toronto Stocks Advance; Docebo Shares Jump on 4Q Profit, Revenue Beat
By Adriano Marchese
Toronto-listed stocks were higher mid-trading on Friday, with the S&P/TSX Composite Index on track to cap off the shortened week slightly ahead.
Most sectors were in positive territory at noon, led by continued strong gains in tech, followed by commercial services and health tech. Of the few decliners in the session, materials, distribution services and consumer discretionary stocks were the main laggards.
Canada's S&P/TSX Composite Index was 0.38% higher at midday, at 21400.02, and the blue-chip S&P/TSX 60 rose by 0.48%, to 1294.54.
Docebo's shares were sharply up at midday, trading 16% higher, at 71.69 Canadian dollars (US$53.17), after the technology company's profit in the latest quarter roughly doubled on the back of stronger-than expected revenue.
Other market movers:
CI Financial's stock rose by 6%, to C$16.79, after the Canadian asset and wealth manager's fourth-quarter earnings beat expectations and it moved to launch a fresh share-buyback program.
Eldorado Gold shares were 9.1% lower, to C$13.84, after the resource company reported higher costs in its 2024 outlook and a lower four-year production outlook.
Shares in Hudbay Minerals were 6.2% higher, at C$7.66, after reporting a profit and higher revenue thanks to strong production in the fourth quarter. The company also said it expects copper production to continue to rise, while gold output is forecast to soften slightly.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
February 23, 2024 12:17 ET (17:17 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks